VD's Model Portfolio & Discussion Thread Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : VD's Model Portfolio & Discussion Thread

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Cytokine1 who wrote (6902)	7/20/1999 11:54:00 PM
From: Vector1	Read Replies (1) of 9719

CYTO, Nasty day. What was that all about. ABSC should get a small boost out of this: -------------------------------------------------------------------------------- 07/20 4:53P (DJ) +DJ Merck To Buy Added Aurora Biosci Ion Probe Reader Sys Story 8127 DJ Merck - Aurora Biosci -2: Under 1997 Pact >ABSC MRK SAN DIEGO (Dow Jones)--Merck & Co. (MRK) exercised an option to purchase additional voltage ion probe reader systems, for use in ion channel drug discovery, from Aurora Bisciences Corp. (ABSC). In a press release Tuesday, Aurora Biosciences said Merck's option to buy the systems was included in the collaborative research and license agreement reached by the companies in December 1997. The screening systems, in conjunction with Aurora's proprietary voltage sensor dyes, were designed to facilitate high-throughput screening for ion channel targets. Merck, Whitehouse Station, N.J., is a pharmaceutical company. Aurora Biosciences is a biotechnology company

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next